To Grip It and Others: I do care when I feel that some posters on this board continually aid the enemies of us and the company either inadvertently or intentionally. For you to understand where I am coming from, I would like to respond to your comments to me item by item along with giving you a little of my background. I retired from a global company with over 90,000 employees. I know how different individuals regard timelines, how process delays can occur, and how government bureaucrats can drive you nuts.
1. You see, because of Nader’s ramblings on this subject it became the focal point of several hit pieces that helped set up on of the most impressive short attacks ever!! We went from $10.01 to $4.65 in about five minutes! So yes, I CARE!
His selling of stock has been covered completely on this board, but it was not a reason our stock went from $10.00 to $4.65. The reason our stock dropped was due to illegal trades. Also covered in detail on this board.
2. I also care that he makes promises that can’t be kept time and time again, I care that he don’t have a BLA submission for HIV and still don’t have any word on the meeting for the “Refusal to File”
The BLA was submitted and the reason for the Refusal to File has been covered. Not unusual for it to happen.
3. and still don’t have any word on the meeting for the “Refusal to File.
Have you thought that the work on the virus program may have been to higher priority? Or the hold up is with the government?
4. I CARE that he said he would have the data “in a few days” and didn’t deliver!
Nader did not give a specific date for the release of the data. For a lot of folks that I have dealt with would not consider the “few days” time frame up yet.
5. These are the things that make life easier for the Citron’s and AF’s is the world easier. These are things that erode shareholder value.
Not remembering that this is a small company battling big competitors and government regs, allows people to be so negative and thus aid the likes of Citron and AF. It is hard to be patient.
